Korean bio ETF Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
00:20
Apr 28
Apr 28
Bio ETF reduces sector volatility.
A Korean biotech ETF is a safer way for beginners to take sector exposure while individual pipeline risk remains high.
MED
11:19
Apr 22
Apr 22
Selective Korean bio rebound opportunity.
The bio sector is being hit by Sam Chun Dang Pharm's problems, but several other Korean bio companies have no company-specific issues and are falling mainly on sector sentiment. Investors without exposure can cautiously accumulate selectively or via a bio ETF that excludes the troubled name, expecting a rebound when foreign investors return.
MED
About Korean bio ETF Investor Commentary
Across the available history and selected sources, Buzzberg tracks Korean bio ETF across 2 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 50% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: Lee Kwon-hee.